| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 04/06/2004 | US6716414 Aerosol solution for use in an aerosol inhaler |
| 04/01/2004 | WO2004026262A2 Abuse-resistant pharmaceutical compositions |
| 04/01/2004 | WO2004026260A2 Prophylactic and therapeutic hiv aptamers |
| 04/01/2004 | WO2004026257A2 Treatment of irritable bowel syndrome and related bowel diseases |
| 04/01/2004 | WO2004026254A2 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b |
| 04/01/2004 | WO2004026253A2 Novel lapacho compounds and methods of use thereof |
| 04/01/2004 | WO2004026249A2 Methods and compositions for preventing skin damage |
| 04/01/2004 | WO2004026248A2 Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators |
| 04/01/2004 | WO2004026237A2 Compounds for the treatment of premature ejaculation |
| 04/01/2004 | WO2004026236A2 Cyclopentyl indole derivatives |
| 04/01/2004 | WO2004026232A2 Vaginal health products |
| 04/01/2004 | WO2004026228A2 Method for reducing morbidity and mortality in critically ill patients |
| 04/01/2004 | WO2004026227A2 A METHOD FOR GENERATION OF A RANDOM RNAi LIBRARY AND ITS APPLICATION IN CELL-BASED SCREENS |
| 04/01/2004 | WO2004026224A2 Process for preparing prostaglandin derivatives and starting materials for the same |
| 04/01/2004 | WO2004026223A2 CONTINUOUS PROCESS FOR THE PRODUCTION OF OPTICALLY PURE (S)-β HYDROXY-Ϝ-BUTYROLACTONE |
| 04/01/2004 | WO2003099281A3 Administration of a partial fatty acid inhibitor such as ranolazine for the treatment of diabetes |
| 04/01/2004 | WO2003063773A3 Differentially-regulated prostate cancer genes |
| 04/01/2004 | WO2003060090A3 Novel cytokine zcytor17 ligand |
| 04/01/2004 | US20040063915 Comprises protein polymers coated with metal for preparation of tubulin-based cytoskeltal fibers |
| 04/01/2004 | US20040063790 By administering an organic peptidomimetic vibronectin receptor alpha v beta 3 antagonist of given structures |
| 04/01/2004 | US20040063787 Vaginal health products |
| 04/01/2004 | US20040063768 Cyclopentylindole derivatives are useful for the treatment of depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder, post-trauma stress, substance abuse and sexual disorders |
| 04/01/2004 | US20040063767 Reacting an alpha-substituted ketone with a cyclictetramine to form quaternaryammonium salt, reacting the salt with an acid to form alpha-amino ketone, reacting ketone with alpha-substitued acyl derivative in presence of a base |
| 04/01/2004 | US20040063759 Administering to a mammal, for treatment or prevention of conditions that can be treated or prevented by antagonizing the CCR1 receptor in a mammal, a piperidinone compound |
| 04/01/2004 | US20040063747 Local anesthetic methods and kits |
| 04/01/2004 | US20040063718 Targeted therapeutics and uses thereof |
| 04/01/2004 | US20040063717 Employing fatty acid oxidation inhibitor; lowering HbA1c, glucose, total cholesterol and/or triglyceride plasma levels; increasing high density lipoprotein concentration; minimizing side effects; ranolazine |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063622 Methods and compositions for treating flaviviruses and pestiviruses |
| 04/01/2004 | US20040062768 Compositions and methods for treating hyperimmune response in the eye |
| 04/01/2004 | US20040062724 Thin, flexible, multilayer film; applying, adhesion to teeth; supplying active materials |
| 04/01/2004 | CA2695720A1 Method of producing epothilone b by culturing sorangium cellulosum in a medium comprising propionic acid |
| 04/01/2004 | CA2695671A1 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b |
| 04/01/2004 | CA2499655A1 Continuous process for the production of optically pure (s)-.beta.-hydroxy-.gamma.-butyrolactone |
| 04/01/2004 | CA2499150A1 Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators |
| 04/01/2004 | CA2498325A1 Prophylactic and therapeutic hiv aptamers |
| 03/31/2004 | EP1403265A1 Industrial process for the synthesis of 5-[bis(carboxymethyl)amino]-3-carboxymethyl-4-cyano-2-thiophene-carboxylic acid tetraesters and use for the synthesis of ranetic acid divalent salts and hydrates thereof |
| 03/31/2004 | EP1402266A2 Determination of risk and treatment of complications of prematurity |
| 03/31/2004 | EP1401828A1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 03/31/2004 | EP1401813A1 New indole derivatives with 5-ht6 receptor affinity |
| 03/31/2004 | EP1401502A1 Pharmaceutical formulation |
| 03/31/2004 | EP1401485A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 4-(2- 4-methane sulfonyl oxyphenyl ethoxy)phenyl] propanoic acid or 3- 4- 2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl -(s)-2-ethoxy propanoic acid and insulin |
| 03/31/2004 | EP1401466A1 Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue |
| 03/31/2004 | EP1401465A2 Pharmaceutical composition for the treatment of viral infection |
| 03/31/2004 | EP1401461A2 Selective cox-2 inhibition from edible plant extracts |
| 03/31/2004 | EP1181294B1 Novel derivatives and analogues of galanthamin |
| 03/31/2004 | EP0783325B2 Contrast agent |
| 03/31/2004 | EP0681477B1 Genetic modification of neural stem cells |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486176A Pharmaceutical compositions comprising amlodipine maleate |
| 03/30/2004 | US6713092 Withania Somnifera composition, method for obtaining same and pharmaceutical, nutritional and personal care formulations thereof |
| 03/30/2004 | US6713047 Mixture of hfa 134a and hfa 227 allows modulation of the mass median aerodynamic diameter (mmad) of the aerosol particles to target specific regions of the repiratory tract |
| 03/25/2004 | WO2004024909A2 Recombinant colstridium neurotoxin fragments |
| 03/25/2004 | WO2004024189A1 Stable immunogenic product comprising antigenic heterocomplexes |
| 03/25/2004 | WO2004024097A2 Compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024089A2 Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing |
| 03/25/2004 | WO2004024088A2 Design of chemokine analogs for the treatment of human diseases |
| 03/25/2004 | WO2004024087A2 Methods of diagnosing and treating hyperproliferative disorders |
| 03/25/2004 | WO2004024086A2 Compounds, compositions and methods |
| 03/25/2004 | WO2004024084A2 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 03/25/2004 | WO2004024078A2 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors |
| 03/25/2004 | WO2004024077A2 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | WO2004024076A2 Novel compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024075A2 Chemokine receptor antagonists as therapeutic agents |
| 03/25/2004 | WO2004024074A2 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators |
| 03/25/2004 | WO2004024073A2 Use of statins in the prevention and treatment of radiation injury and other disorders associated with reduced endothelial thrombomodulin |
| 03/25/2004 | WO2004024071A2 A composition for treating aids and associated conditions |
| 03/25/2004 | WO2004024070A2 Factors that bind intestinal toxins |
| 03/25/2004 | WO2004024068A2 Novel composition and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024066A2 Method of treating diabetes and related conditions |
| 03/25/2004 | WO2003104207A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/25/2004 | WO2003094842A3 Conjugates comprising central nervous system active drug |
| 03/25/2004 | WO2003087050A3 Novel perindopril salt and pharmaceutical compositions containing same |
| 03/25/2004 | WO2003086322A3 Low power laser therapy control |
| 03/25/2004 | WO2003082260A3 Tuberculosis treatment using pleuromutilin derivatives |
| 03/25/2004 | WO2003015812A3 Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/25/2004 | US20040059134 Introducing in a reactor a5-amino-3-(carboxyalkyl)-4-cyano-2-thiophenecarboxylic acid, potassium carbonate and a quaternaryammonium salt as catalyst acetone solvent and methyl bromo acetate, heating and cooling |
| 03/25/2004 | US20040059132 Reacting an indolin-2-one derivative with substituted benzyl halide to form substituted N-benzyl indolin-2-one derivatives have an affinity for oxytocin receptors |
| 03/25/2004 | US20040059002 Sustained release delivery of amphetamine salts |
| 03/25/2004 | US20040058935 Crystals; storage stability; psychological disorders |
| 03/25/2004 | US20040058908 Mixture of bile acid transport inhibitor, cholesteryl ester transport protein inhibitor, fibric acid, nicotinic acid, microsomal triglyceride transfer protein inhibitor and sterols |
| 03/25/2004 | US20040058414 Preparing antibody capable of binding and inhibiting activity of interleukin-2 and receptor, herpes viral epitopes and interferon receptors; diagnosis and treatment of viral and autoimmune diseases |
| 03/25/2004 | US20040057950 Overexpression of which can lead to tumorigenesis; useful in treatment of tumors of breast, lung, colon, kidney, bladder, head and neck, ovary, prostate, and brain |
| 03/25/2004 | CA2499214A1 Stable immunogenic product comprising antigenic heterocomplexes |
| 03/25/2004 | CA2498928A1 Rb pathway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 03/25/2004 | CA2498723A1 Design of chemokine analogs for the treatment of human diseases |
| 03/25/2004 | CA2498502A1 Recombinant clostridial toxin fragments with proteolytic activation |
| 03/25/2004 | CA2498399A1 Method of treating diabetes and related conditions |
| 03/25/2004 | CA2498274A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |
| 03/25/2004 | CA2498237A1 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators |
| 03/25/2004 | CA2498225A1 Factors that bind intestinal toxins |
| 03/25/2004 | CA2498111A1 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors |
| 03/25/2004 | CA2498108A1 A composition for treating aids and associated conditions |
| 03/25/2004 | CA2498008A1 Novel composition and methods for the treatment of immune related diseases |
| 03/25/2004 | CA2497661A1 Compositions and methods for the diagnosis of immune related diseases using pro71061 |
| 03/25/2004 | CA2497337A1 Novel composition and methods for the treatment of psoriasis |
| 03/24/2004 | EP1399445A2 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 03/24/2004 | EP1399166A1 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- 4-(2- 4-METHANE SULFONYL OXYPHENYL ETHOXY) PHENYL] PROPANOIC ACID OR 3- 4- 2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA |